A carregar...
Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece
BACKGROUND: Imiquimod 3.75% is a field‐directed treatment for actinic keratosis that can detect and treat clinical and subclinical lesions across an entire sun‐exposed field. The detection of subclinical lesions is evidenced by an increase in lesions to the maximum lesion count during treatment (L (...
Na minha lista:
| Publicado no: | Int J Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850341/ https://ncbi.nlm.nih.gov/pubmed/30779341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijd.14397 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|